Investment analysts at StockNews.com assumed coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Get Rating) in a research note issued on Sunday. The firm set a “sell” rating on the stock. Tonix Pharmaceuticals Price Performance Shares of TNXP opened at $0.40 on Friday. The firm has a market capitalization of $23.29 million, a price-to-earnings ratio […]
